| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $11.5M | $5.4M | $962.0K |
| YoY Revenue Growth % | +114.3% | +459.3% | — |
| Gross Profit | $913.0K | -$2.8M | — |
| Gross Margin % | 7.9% | -50.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$19.9M | -$29.2M | -$54.5M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$23.70B | -$34.93B | -$51.37B |
| EBITDA (Normalized) | -$19.8M | -$29.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$10.4M | -$14.8M | -$15.4M |
| Capital Expenditures (CapEx) | $94.0K | $0 | — |
| Free Cash Flow (FCF) | -$10.5M | -$14.8M | -$15.4M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $512.0K | $138.0K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $6.4M | $7.1M | — |